Drug Discovery with Machine Learning
Data Skeptic21 Dec 2018

Drug Discovery with Machine Learning

In today's episode, Kyle chats with Alexander Zhebrak, CTO of Insilico Medicine, Inc.

Insilico self describes as artificial intelligence for drug discovery, biomarker development, and aging research.

The conversation in this episode explores the ways in which machine learning, in particular, deep learning, is contributing to the advancement of drug discovery. This happens not just through research but also through software development. Insilico works on data pipelines and tools like MOSES, a benchmarking platform to support research on machine learning for drug discovery. The MOSES platform provides a standardized benchmarking dataset, a set of open-sourced models with unified implementation, and metrics to evaluate and assess their performance.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(601)

Populärt inom Vetenskap

allt-du-velat-veta
dumma-manniskor
p3-dystopia
rss-ufobortom-rimligt-tvivel
ufo-sverige
kapitalet-en-podd-om-ekonomi
sexet
medicinvetarna
svd-nyhetsartiklar
rss-vetenskapsradion
hacka-livet
rss-vetenskapsradion-2
paranormalt-med-caroline-giertz
det-morka-psyket
ufo-sverige-2
rss-spraket
halsorevolutionen
rss-klotet
dumforklarat
ideer-som-forandrar-varlden